![](https://static.scientificamerican.com/sciam/cache/file/E81FBF4C-6E37-4F19-A2CC96007CFF0F65_agenda.jpg?w=275&h=154&fit=crop)
First Proven Malaria Vaccine Rolled Out in Africa—But Doubts Linger
The vaccine is up to 40 percent effective at preventing malaria in young children
The vaccine is up to 40 percent effective at preventing malaria in young children
Treatments based on the “amyloid hypothesis” have failed; it’s time to focus on inflammation instead
U.S. agencies warn doctors not to abruptly cut off the medications for long-time users
One in three gluten-free dishes tested at restaurants contained gluten—especially GF pizzas and pastas. Christopher Intagliata reports.
It can help with diagnosis but not yet with helping physicians and patients decide what to do with the information
Metabolic therapy is showing promise in robbing malignant cells of their primary energy source
An experimental drug for hepatitis D triggers a cellular waste disposal system to rid mice brains of the tau protein, a major culprit in neurodegenerative disease
Trial failure raises doubts about amyloid as a target for drug development
Propofol reduces the intensity of traumatic memories
The new drug, Zulresso, can work in days, not the weeks it takes for current treatments
Medical researcher Steffanie Strathdee needed to save the life of her husband, researcher Tom Patterson, when he contracted one of the world's worst infections. She turned to phage therapy: using a virus to kill the bacteria...
Thyroid hormone, which helps warm-blooded animals regulate body temperature, also appears to put a halt on heart regeneration. Christopher Intagliata reports.
Nasal spray related to the anesthetic/street drug ketamine targets treatment-resistant patients
10 years after the so-called “Berlin Patient,” a second man has been put into sustained remission
For the best minds to solve some of medicine’s biggest problems, the right environment can make a big difference
Johnson & Johnson has submitted its esketamine for regulatory approval, but researchers still don't understand how the fast-acting antidepressant lifts moods
Biology at the center of last year’s contentious gene-edited twins result may hold other benefits for brain injury
A study shows the power of the “argument dilution effect”
Plasma from young people offers “no proven clinical benefit” as a treatment against aging or Alzheimer’s disease, the agency says
A tortoise and a puffer fish inspire technology to overcome the multibillion-dollar nonadherence problem
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account